{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:04:52Z","timestamp":1781701492266,"version":"3.54.5"},"update-to":[{"DOI":"10.3389\/fimmu.2026.1824802","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000}}],"reference-count":0,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031810","name":"Vivet Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031810","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2026.1899342","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:45:17Z","timestamp":1781700317000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction: VTX-PID as a novel recombinant immunoglobulin G\u2013degrading enzyme (IdeS) for efficient AAV-based gene therapy in participants with neutralizing antibodies: results of the phase I first-in-human NAVIgATE study"],"prefix":"10.3389","volume":"17","author":[{"given":"Bernard","family":"Benichou","sequence":"first","affiliation":[{"name":"Vivet Therapeutics SAS","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainard","family":"Fuhr","sequence":"additional","affiliation":[{"name":"Parexel International GmbH","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Vernadal","sequence":"additional","affiliation":[{"name":"Vivet Therapeutics SAS","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Valero","sequence":"additional","affiliation":[{"name":"Vivet Therapeutics SAS","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanche","family":"Tamarit","sequence":"additional","affiliation":[{"name":"Vivet Therapeutics SAS","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Ferrer","sequence":"additional","affiliation":[{"name":"Vivet Therapeutics SAS","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Gonzalez-Aseguinolaza","sequence":"additional","affiliation":[{"name":"DNA & RNA Medicine Division, Gene Therapy for Rare Diseases Department, Center for Applied Medical Research (CIMA), University of Navarra, IdisNA, Pamplona","place":["Navarra, Spain"]},{"name":"Vivet Therapeutics SL","place":["Pamplona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Douar","sequence":"additional","affiliation":[{"name":"Vivet Therapeutics SAS","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Froissart","sequence":"additional","affiliation":[{"name":"Lausanne University Hospital and University of Lausanne","place":["Lausanne, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelise","family":"Brossel","sequence":"additional","affiliation":[{"name":"Vivet Therapeutics SAS","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Floettmann","sequence":"additional","affiliation":[{"name":"Parexel International GmbH","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Del Bene","sequence":"additional","affiliation":[{"name":"Parexel International SRL","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Bouquet","sequence":"additional","affiliation":[{"name":"Vivet Therapeutics SAS","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Combal","sequence":"additional","affiliation":[{"name":"Vivet Therapeutics SAS","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,17]]},"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1899342\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:45:19Z","timestamp":1781700319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1899342\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":0,"alternative-id":["10.3389\/fimmu.2026.1899342"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1899342","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"article-number":"1899342"}}